ADVIA CENTAUR XP MYOGLOBIN ASSAY N/A 09011232

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2013-04-17 for ADVIA CENTAUR XP MYOGLOBIN ASSAY N/A 09011232 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[3275271] Falsely low advia centaur xp myoglobin test results were obtained on a patient sample and considered discordant when compared to repeat test results on alternate advia centaur xp system. There was no report of patient treatment being prescribed or altered and there was no report of adverse health consequences due to the discordant advia centaur xp myoglobin results.
Patient Sequence No: 1, Text Type: D, B5


[10667482] The cause for the discordant advia centaur xp myoglobin result is unknown. The investigation is ongoing. No conclusion can be drawn. The ifu states in the summary and explanation of the test: "myoglobin has a negative predictive value of 99%, which improves the rule out capabilities of the emergency department and helps reduce the number of patients inappropriately admitted to the coronary care units with symptoms atypical of acute myocardial infarction. When used in combination with other cardiac markers such as ck-mb or troponin i, myoglobin is a valuable diagnostic tool to be used in the early evaluation of the potential acute myocardial infarction patient. "
Patient Sequence No: 1, Text Type: N, H10


[34886859] Siemens filed the initial mdr on april 17, 2013. 09/23/2013 additional information: a siemens field service engineer (fse) was sent to the customer site. The fse verified that the aspiration probes have good functionality. The fse checked the sample probe to cuvette calibration and adjusted properly. The discordant patient sample was run and the results were good. The quality control was run and the results were acceptable. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2013-00078
MDR Report Key3062685
Report Source05,06
Date Received2013-04-17
Date of Report2013-03-21
Date of Event2013-03-21
Date Mfgr Received2013-09-12
Date Added to Maude2013-06-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP MYOGLOBIN ASSAY
Generic NameMYOGLOBIN IMMUNOASSAY
Product CodeDDR
Date Received2013-04-17
Model NumberN/A
Catalog Number09011232
Lot Number176
ID NumberN/A
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2013-04-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.